Market Overview

UPDATE: Teva Posts Upbeat Q1 Profit, Declares Dividend

Related TEVA
UPDATE: Sterne Agee Upgrades Teva Pharmaceutical
Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition
Sofinnova Ventures Closes $500M Fund (Fox Business)

Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) posted a rise in its first-quarter profit.

Its quarterly profit climbed to $859 million, or $0.97 per share, versus $761 million, or $0.84 per share, in the year-ago quarter. Excluding one-time items, Teva earned $1.47 per share, up from $1.04 per share. Its revenue climbed 25% to $5.1 billion.

Analysts were expecting earnings of $1.44 per share on revenue of $5.5 billion.

U.S. sales surged 46% to $2.8 billion. European sales fell 2% to $1.3 billion.

Teva also declared a quarterly cash dividend of 1 shekel (26.3 cents) per share.

Teva shares closed at $44.47 yesterday.

Posted-In: EarningsEarnings News

 

Related Articles (TEVA)

Around the Web, We're Loving...

Get Benzinga's Newsletters